Arimidex and Neoplasm progression - a phase IV clinical study of FDA data
Summary:
Neoplasm progression is reported as a side effect among people who take Arimidex (anastrozole), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Zometa, and have Breast cancer metastatic.
The phase IV clinical study analyzes which people have Neoplasm progression when taking Arimidex. It is created by eHealthMe based on reports of 21,680 people who have side effects when taking Arimidex from the FDA, and is updated regularly.
What is Arimidex?
Arimidex has active ingredients of anastrozole. It is often used in breast cancer. eHealthMe is studying from 22,642 Arimidex users. Check the latest studies of Arimidex.
What is Neoplasm progression?
Neoplasm progression (growth of tumour) is found to be associated with 1,068 drugs and 914 conditions by eHealthMe. Check the latest studies of Neoplasm progression.
21,680 people reported to have side effects when taking Arimidex.
Among them, 285 people (1.31%) have Neoplasm progression.
Among these 285 people:
How long have people been on Arimidex when they have Neoplasm progression? *
What is the gender of people who have Neoplasm progression when taking Arimidex? *
What is the age of people who have Neoplasm progression when taking Arimidex? *
What are other drugs people take besides Arimidex? *
What are other side effects people have besides Neoplasm progression? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Arimidex and have Neoplasm progression?
- Check whether Neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Arimidex:
- Arimidex (22,642 reports)
Neoplasm progression treatments and more:
- Neoplasm progression (41,778 reports)
How severe was Neoplasm progression and when was it recovered:
Expand to all the drugs that have ingredients of anastrozole:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Arimidex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Neoplasm progression:
- Neoplasm progression (1,068 drugs)
Browse all the conditions that are associated with Neoplasm progression:
- Neoplasm progression (914 conditions)
Related publications that referenced our studies
- Manjunatha N, Ganjekar S, Mahendra JV, Kilara N, Srinivasa R, "Tardive Dyskinesia Associated With Anastrozole", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
- Manjunatha N, Ganjekar S, Mahendra JV, Kilara N, Srinivasa R, "Tardive Dyskinesia Associated With Anastrozole", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on anastrozole (the active ingredients of Arimidex) and Arimidex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Grape Seed cause Aphthous Stomatitis? - a second ago
- Adderall vs. Atomoxetine Hydrochloride, side effect and effectiveness comparison - 3 seconds ago
- Chest Pain and drugs of ingredients of oats - 11 seconds ago
- Drug interactions of Abelcet and Ceftazidime - 13 seconds ago
- Injury and drugs of ingredients of aspirin; carisoprodol - 26 seconds ago
- Could Revlimid cause Mitral Valve Incompetence? - 26 seconds ago
- Could Revlimid cause Cuts And Puncture Wounds? - 30 seconds ago
- Isoptin vs. Avapro, side effect and effectiveness comparison - 35 seconds ago
- Spiriva and Abdominal Pain Upper for Women aged 60+ - 37 seconds ago
- Could Remicade cause Lung Nodule? - 43 seconds ago